Cardinal Health, Inc. (NYSE:CAH)‘s stock had its “hold” rating reaffirmed by equities researchers at Needham & Company LLC in a research note issued on Thursday.

Other equities research analysts have also recently issued reports about the stock. BidaskClub cut shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 11th. Cowen and Company raised shares of Cardinal Health to a “buy” rating and set a $74.00 price target for the company in a research report on Tuesday. Jefferies Group LLC reissued a “hold” rating and issued a $77.00 price target on shares of Cardinal Health in a research report on Thursday, July 27th. Robert W. Baird reissued a “hold” rating and issued a $73.00 price target on shares of Cardinal Health in a research report on Sunday, September 17th. Finally, UBS AG reaffirmed a “neutral” rating and issued a $76.00 target price (down from $79.00) on shares of Cardinal Health in a report on Thursday, August 3rd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $76.54.

Shares of Cardinal Health (NYSE:CAH) traded up 1.3622% during trading on Thursday, reaching $66.7166. The company had a trading volume of 919,323 shares. The firm has a 50-day moving average of $67.24 and a 200 day moving average of $73.03. Cardinal Health has a 1-year low of $62.70 and a 1-year high of $84.88. The firm has a market capitalization of $21.11 billion, a PE ratio of 16.5550 and a beta of 0.86.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.07. Cardinal Health had a net margin of 0.99% and a return on equity of 26.20%. The firm had revenue of $32.97 billion during the quarter, compared to analysts’ expectations of $32.73 billion. During the same period in the previous year, the company earned $1.14 earnings per share. Cardinal Health’s quarterly revenue was up 5.0% compared to the same quarter last year. Analysts expect that Cardinal Health will post $4.95 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.americanbankingnews.com/2017/10/12/cardinal-health-inc-cah-stock-rating-reaffirmed-by-needham-company-llc.html.

Several institutional investors have recently modified their holdings of CAH. Victory Capital Management Inc. increased its stake in shares of Cardinal Health by 15.7% during the first quarter. Victory Capital Management Inc. now owns 20,291 shares of the company’s stock worth $1,655,000 after acquiring an additional 2,760 shares during the period. Comerica Securities Inc. increased its stake in shares of Cardinal Health by 3.0% during the first quarter. Comerica Securities Inc. now owns 40,579 shares of the company’s stock worth $3,309,000 after acquiring an additional 1,190 shares during the period. Sivik Global Healthcare LLC acquired a new position in shares of Cardinal Health during the first quarter worth about $2,854,000. Ariel Investments LLC increased its stake in shares of Cardinal Health by 1,944.5% during the first quarter. Ariel Investments LLC now owns 746,789 shares of the company’s stock worth $60,901,000 after acquiring an additional 710,263 shares during the period. Finally, Spark Investment Management LLC increased its stake in shares of Cardinal Health by 21.2% during the first quarter. Spark Investment Management LLC now owns 127,700 shares of the company’s stock worth $10,413,000 after acquiring an additional 22,300 shares during the period. Institutional investors and hedge funds own 87.98% of the company’s stock.

About Cardinal Health

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Analyst Recommendations for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.